Kevin Church Athira Pharma, Inc. (ATHA) insider trading activity
Kevin Church is CHIEF SCIENTIFIC OFFICER of Athira Pharma, Inc.. Currently has a direct ownership of 72,668 shares of ATHA, which is worth approximately $190,390. The most recent transaction as insider was on Nov 20, 2023, when has been sold 3,397 shares (Common Stock) at a price of $1.34 per share, resulting in proceeds of $4,551. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
72.7K
0%
3M change
4.9%
12M change
Total Value Held
$190,390
KEVIN CHURCH Transaction History
KC
Kevin Church
CHIEF SCIENTIFIC OFFICER
Bothell, WA